Melatonin is an established hormone supplement and has been well recognized for its effect on the circadian cycle to improve sleep, REM (rapid eye movement), and aiding in jetlag recovery. The utility of melatonin extends beyond sleep aid, however. This hormone also possesses less well-known antioxidant action and even robust anticancer activity. Melatonin may be a key supplement for addressing age-related neurologic decline while serving as a valuable adjunctive cancer treatment that reduces drug resistance in tumors and downregulates angiogenesis. In immunotherapy, melatonin activates Natural Killer (NK) cells nested within tumoral tissue and does not have the side effect profile of other immunoreactive agents used for chemotherapy. Since melatonin is found in high concentrations in the brain and other hormone-linked tissues, the relevance of melatonin is increased for the treatment of estrogen-linked cancers. The immunomodulatory effect of melatonin may also help with chronic inflammation seen in patients with autoimmune disorders. All of these effects together represent a unique and versatile therapeutic agent for integrative medicine. No other commercially available drug possesses all of these therapeutic mechanisms while having a very minimal side effect profile and being considered overall to be safe to use. Currently, melatonin is underutilized in medicine, especially in the field of integrative oncology and represents a crucial supportive adjuvant to improve the lives of patients .
Manchester, L.C., Poeggeler, B., Alvares, F.L., Ogden, G.B. and Reiter, R.J. (1995) Melatonin Immunoreactivity in the Photosynthetic Prokaryote Rhodospirillum rubrum: Implications for an Ancient Antioxidant System. Cellular and Molecular Biology Research, 41, 391-395.
Suofu, Y., et al. (2017) Dual Role of Mitochondria in Producing Melatonin and Driving GPCR Signaling to Block Cytochrome c Release. Proceedings of the National Academy of Sciences, 114, E7997-E8006. https://doi.org/10.1073/pnas.1705768114
Venegas, C., et al. (2012) Extrapineal Melatonin: Analysis of Its Subcellular Distribution and Daily Fluctuations. Journal of Pineal Research, 52, 217-227. https://doi.org/10.1111/j.1600-079X.2011.00931.x
Auld, F., Maschauer, E.L., Morrison, I., Skene, D.J. and Riha, R.L. (2017) Evidence for the Efficacy of Melatonin in the Treatment of Primary Adult Sleep Disorders. Sleep Medicine Reviews, 34, 10-22. https://doi.org/10.1016/j.smrv.2016.06.005
Karasek, M. (2004) Melatonin, Human Aging, and Age-Related Diseases. Experimental Gerontology, 39, 1723-1729. https://doi.org/10.1016/j.exger.2004.04.012
Buscemi, N. (2004) Melatonin for treatment of sleep disorders. Agency for Healthcare Research and Quality.
Matheson, E. and Hainer, B.L. (2017) Insomnia: Pharmacologic Therapy. American Family Physician, 96, 29-35.
A and C Black (2008) British National Formulary.
(2005) Melatonin. Alternative Medicine Review, 10, 326-336.
Escames, G., et al. (2010) The Role of Mitochondria in Brain Aging and the Effects of Melatonin. Current Neuropharmacology, 8, 182-193. https://doi.org/10.2174/157015910792246245
Malhotra, S., Sawhney, G. and Pandhi, P. (2004) The Therapeutic Potential of Melatonin: A Review of the Science. Medscape General Medicine, 6, 46.
Saumen Kumar, M. and Sourav, E. (2015) Gut Melatonin in Vertebrates: Chronobiology and Physiology. Frontiers in Endocrinology (Lausanne), 6, 112. https://doi.org/10.3389/fendo.2015.00112
Tosini, G., Ferguson, I. and Tsubota, K. (2016) Effects of Blue Light on the Circadian System and Eye Physiology. Molecular Vision, 22, 61-72.
Scheer, F.A.J.L. and Czeisler, C.A. (2005) Melatonin, Sleep, and Circadian Rhythms. Sleep Medicine Reviews, 9, 5-9. https://doi.org/10.1016/j.smrv.2004.11.004
Pro-Apoptosis
Immune System Activation
Cancer Adjuvant
Chemotherapy Synergy
Reiter, R.J., Paredes, S.D., Korkmaz, A., Jou, M.-J. and Tan, D.-X. (2008) Melatonin Combats Molecular Terrorism at the Mitochondrial Level. Interdisciplinary Toxicology, 1, 137-149. https://doi.org/10.2478/v10102-010-0030-2
Li, Y., et al. (2017) Melatonin for the Prevention and Treatment of Cancer. Oncotarget, 8, 39896-39921. https://doi.org/10.18632/oncotarget.16379
Xie, W., et al. (2017) Melatonin Potentiates “Inside-Out” Nano-Thermotherapy in Human Breast Cancer Cells: A Potential Cancer Target Multimodality Treatment Based on Melatonin-Loaded Nanocomposite Particles. International Journal of Nanomedicine, 12, 7351-7363. https://doi.org/10.2147/IJN.S148520
Shiu, S.Y.W. (2007) Towards Rational and Evidence-Based Use of Melatonin in Prostate Cancer Prevention and Treatment. Journal of Pineal Research, 43, 1-9. https://doi.org/10.1111/j.1600-079X.2007.00451.x
Wei, X., et al. (2018) Hyperbaric Oxygen Treatment Sensitizes Gastric Cancer Cells to Melatonin-Induced Apoptosis through Multiple Pathways. Journal of Cellular Biochemistry, 119, 6723-6731. https://doi.org/10.1002/jcb.26864
Kvietkauskas, M., et al. (2020) The Role of Melatonin in Colorectal Cancer Treatment: A Comprehensive Review. Therapeutic Advances in Medical Oncology, 12, 1758835920931714. https://doi.org/10.1177/1758835920931714
Yang, Y.-C., et al. (2019) Melatonin Reduces Lung Cancer Stemness through Inhibiting of PLC, ERK, p38, β-Catenin, and Twist Pathways. Environmental Toxicology, 34, 203-209. https://doi.org/10.1002/tox.22674
Comai, S., Ochoa-Sanchez, R. and Gobbi, G. (2013) Sleep-Wake Characterization of Double MT1/MT2 Receptor Knockout Mice and Comparison with MT1 and MT2 Receptor Knockout Mice. Behavioural Brain Research, 243, 231-238. https://doi.org/10.1016/j.bbr.2013.01.008
Carrillo-Vico, A., Lardone, P.J., Alvarez-Sánchez, N., Rodríguez-Rodríguez, A. and Guerrero, J.M. (2013) Melatonin: Buffering the Immune System. International Journal of Molecular Sciences, 14, 8638-8683. https://doi.org/10.3390/ijms14048638
Foulkes, N.S., Assone-Corsi, P., Borjigin, J. and Snyder, S.H. (1997) Rhythmic Transcription: The Molecular Basis of Circadian Melatonin Synthesis. Trends in Neurosciences, 20, 487-492. https://doi.org/10.1016/S0166-2236(97)01109-0
Kamal, M., et al. (2015) Convergence of Melatonin and Serotonin (5-HT) Signaling at MT2/5-HT2C Receptor Heteromers. The Journal of Biological Chemistry, 290, 11537-11546. https://doi.org/10.1074/jbc.M114.559542
Christian De, B., et al. (2010) Agomelatine, the First Melatonergic Antidepressant: Discovery, Characterization and Development. Nature Reviews Drug Discovery, 9, 628. https://doi.org/10.1038/nrd3140
Stauch, B., et al. (2019) Structural Basis of Ligand Recognition at the Human MT1 Melatonin Receptor. Nature (London), 569, 284-288. https://doi.org/10.1038/s41586-019-1141-3
Johansson, L.C., et al. (2019) XFEL Structures of the Human MT2 Melatonin Receptor Reveal the Basis of Subtype Selectivity. Nature (London), 569, 289-292. https://doi.org/10.1038/s41586-019-1144-0
Murray, C.J. and Lopez, A.D. (1997) Alternative Projections of Mortality and Disability by Cause 1990-2020: Global Burden of Disease Study. The Lancet (London, England), 349, 1498-1504. https://doi.org/10.1016/S0140-6736(96)07492-2
Golan, D., et al. (2013) The Influence of Vitamin D Supplementation on Melatonin Status in Patients with Multiple Sclerosis. Brain, Behavior, and Immunity, 32, 180-185. https://doi.org/10.1016/j.bbi.2013.04.010
Williams, J.W., et al. (2000) A Systematic Review of Newer Pharmacotherapies for Depression in Adults: Evidence Report Summary. Annals of Internal Medicine, 132, 743-756. https://doi.org/10.7326/0003-4819-132-9-200005020-00011
Anderson, I.M. and Tomenson, B.M. (1995) Treatment Discontinuation with Selective Serotonin Reuptake Inhibitors Compared with Tricyclic Antidepressants: A Meta-Analysis. BMJ: British Medical Journal, 310, 1433. https://doi.org/10.1136/bmj.310.6992.1433
Overstreet, H.D., Pucilowski, H.O., Retton, H.M.-C., Delagrange, H.P. and Guardiola-Lemaitre, H.B. (1998) Effects of Melatonin Receptor Ligands on Swim Test Immobility. NeuroReport, 9, 249-253. https://doi.org/10.1097/00001756-199801260-00014
Micale, V., Arezzi, A., Rampello, L. and Drago, F. (2006) Melatonin Affects the Immobility Time of Rats in the Forced Swim Test: The Role of Serotonin Neurotransmission. European Neuropsychopharmacology, 16, 538-545. https://doi.org/10.1016/j.euroneuro.2006.01.005
Pévet, P. (2016) Melatonin Receptors as Therapeutic Targets in the Suprachiasmatic Nucleus. Expert Opinion on Therapeutic Targets, 20, 1209-1218. https://doi.org/10.1080/14728222.2016.1179284
Esposito, E. and Cuzzocrea, S. (2010) Antiinflammatory Activity of Melatonin in Central Nervous System. Current Neuropharmacology, 8, 228-242. https://doi.org/10.2174/157015910792246155
Mohan, N., Sadeghi, K., Reiter, R.J. and Meltz, M.L. (1995) The Neurohormone Melatonin Inhibits Cytokine, Mitogen and Ionizing Radiation Induced NF-kappa B. Biochemistry and Molecular Biology International, 37, 1063-1070.
Calvo, J.R., González-Yanes, C. and Maldonado, M.D. (2013) The Role of Melatonin in the Cells of the Innate Immunity: A Review. Journal of Pineal Research, 55, 103-120. https://doi.org/10.1111/jpi.12075
Carrillo-Vico, A., Guerrero, J., Lardone, P. and Reiter, R. (2005) A Review of the Multiple Actions of Melatonin on the Immune System. Endocrine, 27, 189-200. https://doi.org/10.1385/ENDO:27:2:189
Molinero, P., Soutto, M., Benot, S., Hmadcha, A. and Guerrero, J.M. (2000) Melatonin Is Responsible for the Nocturnal Increase Observed in Serum and Thymus of Thymosin Alpha1 and Thymulin Concentrations: Observations in Rats and Humans. Journal of Neuroimmunology, 103, 180-188. https://doi.org/10.1016/S0165-5728(99)00237-4
Luchetti, F., et al. (2006) Melatonin Prevents Apoptosis Induced by UV-B Treatment in U937 Cell Line. Journal of Pineal Research, 40, 158-167. https://doi.org/10.1111/j.1600-079X.2005.00293.x
Pedrosa, A.M., et al. (2010) Melatonin Protects CD4+ T Cells from Activation-Induced Cell Death by Blocking NFAT-Mediated CD95 Ligand Upregulation. The Journal of Immunology, 184, 3487-3494. https://doi.org/10.4049/jimmunol.0902961
Sánchez-Barceló, E.J., Mediavilla, M.D., Tan, D.X. and Reiter, R.J. (2010) Clinical Uses of Melatonin: Evaluation of Human Trials. Current Medicinal Chemistry, 17, 2070-2095. https://doi.org/10.2174/092986710791233689
Cos, S. and Sánchez-Barceló, E.J. (1994) Differences between Pulsatile or Continuous Exposure to Melatonin on MCF-7 Human Breast Cancer Cell Proliferation. Cancer Letters, 85, 105-109. https://doi.org/10.1016/0304-3835(94)90245-3
Lissoni, P., et al. (1995) Modulation of Cancer Endocrine Therapy by Melatonin: A Phase II Study of Tamoxifen plus Melatonin in Metastatic Breast Cancer Patients Progressing under Tamoxifen Alone. British Journal of Cancer, 71, 854. https://doi.org/10.1038/bjc.1995.164
Neri, B., et al. (1994) Modulation of Human Lymphoblastoid Interferon Activity by Melatonin in Metastatic Renal Cell Carcinoma. A Phase II Study. Cancer, 73, 3015-3019. https://doi.org/10.1002/1097-0142(19940615)73:12 3.0.CO;2-N
Lissoni, P., et al. (1992) Randomized Study with the Pineal Hormone Melatonin versus Supportive Care Alone in Advanced Nonsmall Cell Lung Cancer Resistant to a First-Line Chemotherapy Containing Cisplatin. Oncology, 49, 336-339. https://doi.org/10.1159/000227068
Aldeghi, R., et al. (1994) Low-Dose Interleukin-2 Subcutaneous Immunotherapy in Association with the Pineal Hormone Melatonin as a First-Line Therapy in Locally Advanced or Metastatic Hepatocellular-Carcinoma. European Journal of Cancer, 30, 167-170. https://doi.org/10.1016/0959-8049(94)90080-9
Lissoni, P., et al. (1994) A Randomized Study with the Pineal Hormone Melatonin versus Supportive Care Alone in Patients with Brain Metastases Due to Solid Neoplasms. Cancer, 73, 699-701. https://doi.org/10.1002/1097-0142(19940201)73:3 3.0.CO;2-L
González-González, A., et al. (2020) Usefulness of Melatonin as Complementary to Chemotherapeutic Agents at Different Stages of the Angiogenic Process. Scientific Reports, 10, Article No. 4790. https://doi.org/10.1038/s41598-020-61622-x
Russo, I. and Russo, J. (1998) Role of Hormones in Mammary Cancer Initiation and Progression. Journal of Mammary Gland Biology and Neoplasia, 3, 49-61. https://doi.org/10.1023/A:1018770218022
Cohen, M., Lippman, M. and Chabner, B. (1978) Role of Pineal Gland in Aetiology and Treatment of Breast Cancer. The Lancet (London, England), 2, 814-816. https://doi.org/10.1016/S0140-6736(78)92591-6
Blask, D., et al. (1991) Pineal Melatonin Inhibition of Tumor Promotion in the N-nitroso-N-methylurea Model of Mammary Carcinogenesis: Potential Involvement of Antiestrogenic Mechanisms in Vivo. Journal of Cancer Research and Clinical Oncology, 117, 526-532. https://doi.org/10.1007/BF01613283
American Cancer Society (2020) Cancer Facts and Figures. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2020/cancer-facts-and-figures-2020.pdf
Pariente, R., Bejarano, I., Rodríguez, A.B., Pariente, J.A. and Espino, J. (2018) Melatonin Increases the Effect of 5-Fluorouracil-Based Chemotherapy in Human Colorectal Adenocarcinoma Cells in Vitro. Molecular and Cellular Biochemistry, 440, 43-51. https://doi.org/10.1007/s11010-017-3154-2
Conant, K. and Gottschall, P. (2005) Matrix Metalloproteinases in the Central Nervous System. Imperial College Press.
Pal, S., Ganguly, K.K. and Chatterjee, A. (2013) Extracellular Matrix Protein Fibronectin Induces Matrix Metalloproteinases in Human Prostate Adenocarcinoma Cells PC-3. Cell Communication and Adhesion, 20, 105-114. https://doi.org/10.3109/15419061.2013.833193
Fridman, R., Toth, M., Chvyrkova, I., Meroueh, S. and Mobashery, S. (2003) Cell Surface Association of Matrix Metalloproteinase-9 (Gelatinase B). Cancer and Metastasis Reviews, 22, 153-166. https://doi.org/10.1023/A:1023091214123
Ramos-Desimone, N., et al. (1999) Activation of Matrix Metalloproteinase-9 (MMP-9) via a Converging Plasmin/Stromelysin-1 Cascade Enhances Tumor Cell Invasion. Journal of Biological Chemistry, 274, 13066-13076. https://doi.org/10.1074/jbc.274.19.13066
Vu, T.H., et al. (1998) MMP-9/Gelatinase B Is a Key Regulator of Growth Plate Angiogenesis and Apoptosis of Hypertrophic Chondrocytes. Cell, 93, 411-422. https://doi.org/10.1016/S0092-8674(00)81169-1
Johnson, M.C., Sung, E.H.-J., Lessner, S.S., Fini, S.M. and Galis, S.Z. (2004) Matrix Metalloproteinase-9 Is Required for Adequate Angiogenic Revascularization of Ischemic Tissues: Potential Role in Capillary Branching. Circulation Research: Journal of the American Heart Association, 94, 262-268. https://doi.org/10.1161/01.RES.0000111527.42357.62
Larsen, P.H., Wells, J.E., Stallcup, W.B., Opdenakker, G. and Yong, V.W. (2003) Matrix Metalloproteinase-9 Facilitates Remyelination in Part by Processing the Inhibitory NG2 Proteoglycan. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 23, 11127-11135. https://doi.org/10.1523/JNEUROSCI.23-35-11127.2003
Ram, M., Sherer, Y. and Shoenfeld, Y. (2006) Matrix Metalloproteinase-9 and Autoimmune Diseases. Journal of Clinical Immunology, 26, 299-307. https://doi.org/10.1007/s10875-006-9022-6
Rohde, L.E., et al. (1999) Matrix Metalloproteinase Inhibition Attenuates Early Left Ventricular Enlargement after Experimental Myocardial Infarction in Mice. Circulation, 99, 3063-3070. https://doi.org/10.1161/01.CIR.99.23.3063
Sellner, J. and Leib, S.L. (2006) In Bacterial Meningitis Cortical Brain Damage Is Associated with Changes in Parenchymal MMP-9/TIMP-1 Ratio and Increased Collagen Type IV Degradation. Neurobiology of Disease, 21, 647-656. https://doi.org/10.1016/j.nbd.2005.09.007
Starckx, S., Van Den Steen, P.E., Verbeek, R., van Noort, J.M. and Opdenakker, G. (2003) A Novel Rationale for Inhibition of Gelatinase B in Multiple Sclerosis: MMP-9 Destroys αB-Crystallin and Generates a Promiscuous T Cell Epitope. Journal of Neuroimmunology, 141, 47-57. https://doi.org/10.1016/S0165-5728(03)00217-0
Vandooren, J., Van den Steen, P.E. and Opdenakker, G. (2013) Biochemistry and Molecular Biology of Gelatinase B or Matrix Metalloproteinase-9 (MMP-9): The Next Decade. Critical Reviews in Biochemistry and Molecular Biology, 48, 222-272. https://doi.org/10.3109/10409238.2013.770819
Egeblad, M. and Werb, Z. (2002) New Functions for the Matrix Metalloproteinases in Cancer Progression. Nature Reviews Cancer, 2, 161-174. https://doi.org/10.1038/nrc745
Iurlaro, et al. (1999) Angiogenesis Extent and Expression of Matrix Metalloproteinase-2 and -9 Correlate with Upgrading and Myometrial Invasion in Endometrial Carcinoma. European Journal of Clinical Investigation, 29, 793-801. https://doi.org/10.1046/j.1365-2362.1999.00532.x
Bergers, G., et al. (2000) Matrix Metalloproteinase-9 Triggers the Angiogenic Switch during Carcinogenesis. Nature Cell Biology, 2, 737-744. https://doi.org/10.1038/35036374
Acuff, H.B., Carter, K.J., Fingleton, B., Gorden, D.L. and Matrisian, L.M. (2006) Matrix Metalloproteinase-9 from Bone Marrow-Derived Cells Contributes to Survival But Not Growth of Tumor Cells in the Lung Microenvironment. Cancer Research, 66, 259-266. https://doi.org/10.1158/0008-5472.CAN-05-2502
Zucker, S., Lysik, R.M., Zarrabi, M.H. and Moll, U. (1993) M(r) 92,000 Type IV Collagenase Is Increased in Plasma of Patients with Colon Cancer and Breast Cancer. Cancer Research, 53, 140-146.
Tochowicz, A., et al. (2007) Crystal Structures of MMP-9 Complexes with Five Inhibitors: Contribution of the Flexible Arg424 Side-Chain to Selectivity. Journal of Molecular Biology, 371, 989-1006. https://doi.org/10.1016/j.jmb.2007.05.068
Ganguly, K., Kundu, P., Banerjee, A., Reiter, R.J. and Swarnakar, S. (2006) Hydrogen Peroxide-Mediated Downregulation of Matrix Metalloprotease-2 in Indomethacin-Induced Acute Gastric Ulceration Is Blocked by Melatonin and Other Antioxidants. Free Radical Biology and Medicine, 41, 911-925. https://doi.org/10.1016/j.freeradbiomed.2006.04.022
Mishra, A., Paul, S. and Swarnakar, S. (2011) Downregulation of Matrix Metalloproteinase-9 by Melatonin during Prevention of Alcohol-Induced Liver Injury in Mice. Biochimie, 93, 854-866. https://doi.org/10.1016/j.biochi.2011.02.007
Motilva, V., García-Maurino, S., Talero, E. and Illanes, M. (2011) New Paradigms in Chronic Intestinal Inflammation and Colon Cancer: Role of Melatonin. Journal of Pineal Research, 51, 44-60. https://doi.org/10.1111/j.1600-079X.2011.00915.x
Galano, A., Tan, D.X. and Reiter, R.J. (2011) Melatonin as a Natural Ally against Oxidative Stress: A Physicochemical Examination. Journal of Pineal Research, 51, 1-16. https://doi.org/10.1111/j.1600-079X.2011.00916.x
Poeggeler, B., et al. (1994) Melatonin—A Highly Potent Endogenous Radical Scavenger and Electron Donor: New Aspects of the Oxidation Chemistry of This Indole Accessed in Vitro. Annals of the New York Academy of Sciences, 738, 419-420. https://doi.org/10.1111/j.1749-6632.1994.tb21831.x
Tan, D.-X., et al. (2002) Chemical and Physical Properties and Potential Mechanisms: Melatonin as a Broad Spectrum Antioxidant and Free Radical Scavenger. Current Topics in Medicinal Chemistry, 2, 181-197. https://doi.org/10.2174/1568026023394443
Rudra, D.S., Pal, U., Maiti, N.C., Reiter, R.J. and Swarnakar, S. (2013) Melatonin Inhibits Matrix Metalloproteinase-9 Activity by Binding to Its Active Site. Journal of Pineal Research, 54, 398-405. https://doi.org/10.1111/jpi.12034
Cutando, A., Lopez-Valverde, A., Arias-Santiago, S., De Vicente, J. and De Diego, R.G. (2012) Role of Melatonin in Cancer Treatment. AntiCancer Research, 32, 2747-2753.
Scheiermann, C., Kunisaki, Y. and Frenette, P.S. (2013) Circadian Control of the Immune System. Nature Reviews Immunology, 13, 190-198. https://doi.org/10.1038/nri3386
Christopher, J.M., Taylor, E.P., Kun, H. and Frank, A.J.L.S. (2016) Circadian Misalignment Increases Cardiovascular Disease Risk Factors in Humans. Proceedings of the National Academy of Sciences, 113, E1402. https://doi.org/10.1073/pnas.1516953113
Jim, H., Tyrer, J., Lin, H., Han, G., Qu, X., Goode, E., Chen, Z., Tsai, Y., Cunningham, J., Iversen, E., Ramus, S., Berchuck, A., Schildkraut, J., Monteiro, A., Gayther, S., Narod, S., Sellers, T., Pharoah, P. and Phelan, C. (2013) Abstract 4850: Variation in Circadian Rhythm Genes Influence Epithelial Ovarian Cancer Risk and Invasiveness. Cancer Research (Chicago, Ill.), 73, 4850. https://doi.org/10.1158/1538-7445.AM2013-4850
Blask, D.E., et al. (2005) Melatonin-Depleted Blood from Premenopausal Women Exposed to Light at Night Stimulates Growth of Human Breast Cancer Xenografts in Nude Rats. Cancer Research, 65, 11174-11184. https://doi.org/10.1158/0008-5472.CAN-05-1945
Lardone, P.J., Carrillo-Vico, A., Molinero, P., Rubio, A. and Guerrero, J.M. (2009) A Novel Interplay between Membrane and Nuclear Melatonin Receptors in Human Lymphocytes: Significance in IL-2 Production. Cellular and Molecular Life Sciences, 66, 516-525. https://doi.org/10.1007/s00018-008-8601-5
Koebel, C.M., et al. (2007) Adaptive Immunity Maintains Occult Cancer in an Equilibrium State. Nature, 450, 903-907. https://doi.org/10.1038/nature06309
Knutson, K.L., Disis, M.L. and Salazar, L.G. (2007) CD4 Regulatory T Cells in Human Cancer Pathogenesis. Cancer Immunology, Immunotherapy, 56, 271-285. https://doi.org/10.1007/s00262-006-0194-y
Liu, H., et al. (2011) Role of CD4+ CD25+ Regulatory T Cells in Melatonin-Mediated Inhibition of Murine Gastric Cancer Cell Growth in Vivo and in Vitro. The Anatomical Record (Hoboken), 294, 781-788. https://doi.org/10.1002/ar.21361
Vigoré, L., et al. (2010) Psychoneuroendocrine Modulation of Regulatory T Lymphocyte System: In Vivo and in Vitro Effects of the Pineal Immunomodulating Hormone Melatonin. In Vivo, 24, 787-789.
Kawaguchi, K., et al. (2019) Alteration of Specific Cytokine Expression Patterns in Patients with Breast Cancer. Scientific Reports, 9, Article No. 2924. https://doi.org/10.1038/s41598-019-39476-9
Marotta, L.L.C. and Polyak, K. (2011) Unraveling the Complexity of Basal-Like Breast Cancer. Oncotarget, 2, 588-589. https://doi.org/10.18632/oncotarget.314
Leek, R.D. and Harris, A.L. (2002) Tumor-Associated Macrophages in Breast Cancer. Journal of Mammary Gland Biology and Neoplasia, 7, 177-189. https://doi.org/10.1023/A:1020304003704
Lacoste, B., et al. (2015) Anatomical and Cellular Localization of Melatonin MT1 and MT2 Receptors in the Adult Rat Brain. Journal of Pineal Research, 58, 397-417. https://doi.org/10.1111/jpi.12224
Reiter, R.J., et al. (2007) Medical Implications of Melatonin: Receptor-Mediated and Receptor-Independent Actions. Advances in Medical Sciences, 52, 11-28.
Slominski, R.M., Reiter, R.J., Schlabritz-Loutsevitch, N., Ostrom, R.S. and Slominski, A.T. (2012) Melatonin Membrane Receptors in Peripheral Tissues: Distribution and Functions. Molecular and Cellular Endocrinology, 351, 152-166. https://doi.org/10.1016/j.mce.2012.01.004
He, B., et al. (2016) The Nuclear Melatonin Receptor RORα Is a Novel Endogenous Defender against Myocardial Ischemia/Reperfusion Injury. Journal of Pineal Research, 60, 313-326. https://doi.org/10.1111/jpi.12312
Lardone, P.J., et al. (2011) Melatonin Synthesized by T Lymphocytes as a Ligand of the Retinoic Acid-Related Orphan Receptor. Journal of Pineal Research, 51, 454-462. https://doi.org/10.1111/j.1600-079X.2011.00909.x
Becker-André, M., et al. (1994) Pineal Gland Hormone Melatonin Binds and Activates an Orphan of the Nuclear Receptor Superfamily. The Journal of Biological Chemistry, 269, 28531-28534.
Pozo, D., et al. (1997) Expression of the Mel1a-Melatonin Receptor mRNA in T and B Subsets of Lymphocytes from Rat Thymus and Spleen. FASEB Journal, 11, 466-473. https://doi.org/10.1096/fasebj.11.6.9194527
Gonzalez-Haba, M.G., Garcia-Maurino, S., Calvo, J.R., Goberna, R. and Guerrero, J.M. (1995) High-Affinity Binding of Melatonin by Human Circulating T Lymphocytes (CD4+). FASEB Journal, 9, 1331-1335. https://doi.org/10.1096/fasebj.9.13.7557023
Ren, W., et al. (2017) Melatonin Signaling in T Cells: Functions and Applications. Journal of Pineal Research, 62, e12394. https://doi.org/10.1111/jpi.12394
Knochelmann, H.M., et al. (2018) When Worlds Collide: Th17 and Treg Cells in Cancer and Autoimmunity. Cellular and Molecular Immunology, 15, 458-469. https://doi.org/10.1038/s41423-018-0004-4
Luo, J., et al. (2020) Effect of Melatonin on T/B Cell Activation and Immune Regulation in Pinealectomy Mice. Life Sciences, 242, Article ID: 117191. https://doi.org/10.1016/j.lfs.2019.117191
Mediavilla, M.D., Sanchez-Barcelo, E.J., Tan, D.X., Manchester, L. and Reiter, R.J. (2010) Basic Mechanisms Involved in the Anti-Cancer Effects of Melatonin. Current Medicinal Chemistry, 17, 4462-4481. https://doi.org/10.2174/092986710794183015
Casado-Zapico, S., et al. (2010) Synergistic Antitumor Effect of Melatonin with Several Chemotherapeutic Drugs on Human Ewing Sarcoma Cancer Cells: Potentiation of the Extrinsic Apoptotic Pathway. Journal of Pineal Research, 48, 72-80. https://doi.org/10.1111/j.1600-079X.2009.00727.x
Reiter, R.J., Tan, D.X., Sainz, R.M., Mayo, J.C. and Lopez-Burillo, S. (2002) Melatonin: Reducing the Toxicity and Increasing the Efficacy of Drugs. Journal of Pharmacy and Pharmacology, 54, 1299-1321. https://doi.org/10.1211/002235702760345374
Benítez-King, G., Soto-Vega, E. and Ramírez-Rodriguez, G. (2009) Melatonin Modulates Microfilament Phenotypes in Epithelial Cells: Implications for Adhesion and Inhibition of Cancer Cell Migration. Histology and Histopathology, 24, 789-799.
Fan, L., Sun, G., Ma, T., Zhong, F. and Wei, W. (2013) Melatonin Overcomes Apoptosis Resistance in Human Hepatocellular Carcinoma by Targeting Survivin and XIAP. Journal of Pineal Research, 55, 174-183. https://doi.org/10.1111/jpi.12060
Cho, C. and Yu, J. (2012) From Inflammation to Cancer: Advances in Diagnosis and Therapy for Gastrointestinal and Hepatological Diseases. In From Inflammation to Cancer. World Scientific Publishing Co. Pte. Ltd. https://doi.org/10.1142/8117
Rauch, D., et al. (2009) Imaging Spontaneous Tumorigenesis: Inflammation Precedes Development of Peripheral NK Tumors. Blood, 113, 1493-1500. https://doi.org/10.1182/blood-2008-07-166462
Zhang, X., et al. (2015) Inflammation-Induced S100A8 Activates Id3 and Promotes Colorectal Tumorigenesis. International Journal of Cancer, 137, 2803-2814. https://doi.org/10.1002/ijc.29671
Urata, Y., et al. (1999) Melatonin Induces γ-Glutamylcysteine Synthetase Mediated by Activator Protein-1 in Human Vascular Endothelial Cells. Free Radical Biology and Medicine, 27, 838-847. https://doi.org/10.1016/S0891-5849(99)00131-8
Hey-Mogensen, M., et al. (2010) Effect of Physical Training on Mitochondrial Respiration and Reactive Oxygen Species Release in Skeletal Muscle in Patients with Obesity and Type 2 Diabetes. Diabetologia, 53, 1976. https://doi.org/10.1007/s00125-010-1813-x
Tan, D.-X., et al. (2000) Melatonin Directly Scavenges Hydrogen Peroxide: A Potentially New Metabolic Pathway of Melatonin Biotransformation. Free Radical Biology and Medicine, 29, 1177-1185. https://doi.org/10.1016/S0891-5849(00)00435-4
Aydogan, S., Yerer, M.B. and Goktas, A. (2006) Melatonin and Nitric Oxide. Journal of Endocrinological Investigation, 29, 281-287. https://doi.org/10.1007/BF03345555
Munn, E.A. (1974) The Structure of Mitochondria. Elsevier, Amsterdam. https://doi.org/10.1016/B978-0-12-510150-9.50008-0
Acuna-Castroviejo, D., Escames, G., León, J., Carazo, A. and Khaldy, H. (2003) Mitochondrial Regulation by Melatonin and Its Metabolites. Advances in Experimental Medicine and Biology, 527, 549. https://doi.org/10.1007/978-1-4615-0135-0_63
Saravanan, K.S., Sindhu, K.M. and Mohanakumar, K.P. (2007) Melatonin Protects against Rotenone-Induced Oxidative Stress in a Hemiparkinsonian Rat Model. Journal of Pineal Research, 42, 247-253. https://doi.org/10.1111/j.1600-079X.2006.00412.x
Stvolinsky, S., Fedorova, N. and Boldyrev, A. (2007) MPTP-Induced Parkinsonian Syndrome in Senescence Accelerated Mice (SAM). Parkinsonism and Related Disorders, 13, S128-S128. https://doi.org/10.1016/S1353-8020(08)70723-5
Acuna-Castroviejo, D., Coto-Montes, A., Monti, M.G., Ortiz, G.G. and Reiter, R.J. (1996) Melatonin Is Protective against MPTP-Induced Striatal and Hippocampal Lesions. Life Sciences, 60, PL23-PL29. https://doi.org/10.1016/S0024-3205(96)00606-6
Túnez, I., Montilla, P., Del Carmen Munoz, M., Feijóo, M. and Salcedo, M. (2004) Protective Effect of Melatonin on 3-Nitropropionic Acid-Induced Oxidative Stress in Synaptosomes in an Animal Model of Huntington’s Disease. Journal of Pineal Research, 37, 252-256. https://doi.org/10.1111/j.1600-079X.2004.00163.x
Yamamoto, H.-A. and Mohanan, P.V. (2002) Melatonin Attenuates Brain Mitochondria DNA Damage Induced by Potassium Cyanide in Vivo and in Vitro. Toxicology, 179, 29-36. https://doi.org/10.1016/S0300-483X(02)00244-5
Yamamoto, H.-A. and Tang, H.-W. (1996) Preventive Effect of Melatonin against Cyanide-Induced Seizures and Lipid Peroxidation in Mice. Neuroscience Letters, 207, 89-92. https://doi.org/10.1016/0304-3940(96)12493-9
Floyd, R.A. and Hensley, K. (2002) Oxidative Stress in Brain Aging: Implications for Therapeutics of Neurodegenerative Diseases. Neurobiology of Aging, 23, 795-807. https://doi.org/10.1016/S0197-4580(02)00019-2
Hill, J.M. and Switzer, R.C. (1984) The Regional Distribution and Cellular Localization of Iron in the Rat Brain. Neuroscience, 11, 595-603. https://doi.org/10.1016/0306-4522(84)90046-0
Sanchez-Moreno, C., Dorfman, S., Lichtenstein, A. and Martin, A. (2004) Dietary Fat Type Affects Vitamins C and E and Biomarkers of Oxidative Status in Peripheral and Brain Tissues of Golden Syrian Hamsters. The Journal of Nutrition, 134, 655-660. https://doi.org/10.1093/jn/134.3.655
Antolín, I., et al. (1996) Neurohormone Melatonin Prevents Cell Damage: Effect on Gene Expression for Antioxidant Enzymes. FASEB Journal, 10, 882-890. https://doi.org/10.1096/fasebj.10.8.8666165
Rosenbluth, J. (1980) Central Myelin in the Mouse Mutant Shiverer. Journal of Comparative Neurology, 194, 639-648. https://doi.org/10.1002/cne.901940310
Hopp, D.C. and Shurtleff, D. (2019) Melatonin: What You Need to Know. https://www.nccih.nih.gov/health/melatonin-what-you-need-to-know
Mayo Clinic Staff (2018) Melatonin. https://www.mayoclinic.org/drugs-supplements-melatonin/art-20363071
(2009) Agomelatine: New Drug. Adverse Effects and No Proven Efficacy. Prescrire International, 18, 241-245.
Costello, R., et al. (2014) The Effectiveness of Melatonin for Promoting Healthy Sleep: A Rapid Evidence Assessment of the Literature. Nutrition Journal, 13, 106. https://doi.org/10.1186/1475-2891-13-106
Hardeland, R., et al. (2008) Melatonergic Drugs in Clinical Practice. Arzneimittel-Forschung, 58, 1-10. https://doi.org/10.1055/s-0031-1296459
Emet, M., et al. (2016) A Review of Melatonin, Its Receptors and Drugs/Bir Melatonin Derlemesi, Reseptorleri ve Ilaclari. Eurasian Journal of Medicine, 48, 135-141. https://doi.org/10.5152/eurasianjmed.2015.0267
Hardeland, R. (2012) Melatonin in Aging and Disease—Multiple Consequences of Reduced Secretion, Options and Limits of Treatment. Aging and Disease, 3, 194-225.
Lin, T.-H., Lai, W.-T. and Sheu, S.-H. (2011) Relationship between Adipokines, Inflammation, Oxidative Stress, Insulin Resistance and Family History of Hypertension in Young-Onset Hypertensives. Journal of the American College of Cardiology, 57, E527. https://doi.org/10.1016/S0735-1097(11)60527-5
Paik, J.K., et al. (2012) Circulating and PBMC Lp-PLA 2 Associate Differently with Oxidative Stress and Subclinical Inflammation in Nonobese Women (Menopausal Status) (Lp-PLA 2 Activity, Inflammation and Oxidative Stress). PLoS ONE, 7, e29675. https://doi.org/10.1371/journal.pone.0029675
Finelli, M. and Oliver, P. (2017) TLDc Proteins: New Players in the Oxidative Stress Response and Neurological Disease. Mammalian Genome, 28, 395-406. https://doi.org/10.1007/s00335-017-9706-7